Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$191.17 - $325.63 $2.77 Million - $4.72 Million
-14,500 Reduced 14.57%
85,000 $27.7 Million
Q3 2023

Oct 26, 2023

BUY
$194.33 - $283.97 $590,763 - $863,268
3,040 Added 3.15%
99,500 $19.8 Million
Q2 2023

Jul 31, 2023

SELL
$223.05 - $302.68 $2.51 Million - $3.4 Million
-11,240 Reduced 10.44%
96,460 $27.5 Million
Q1 2023

Aug 02, 2023

BUY
$175.41 - $217.92 $1.97 Million - $2.45 Million
11,240 Added 11.65%
107,700 $23.4 Million
Q1 2023

Apr 27, 2023

BUY
$175.41 - $217.92 $3.6 Million - $4.47 Million
20,500 Added 23.51%
107,700 $23.4 Million
Q4 2022

Jan 26, 2023

SELL
$204.38 - $296.82 $61,314 - $89,046
-300 Reduced 0.34%
87,200 $17.9 Million
Q3 2022

Oct 27, 2022

BUY
$195.21 - $310.53 $3.57 Million - $5.68 Million
18,300 Added 26.45%
87,500 $24.3 Million
Q2 2022

Jul 25, 2022

BUY
$115.91 - $214.48 $7.01 Million - $13 Million
60,500 Added 695.4%
69,200 $13.2 Million
Q1 2022

Apr 21, 2022

SELL
$127.96 - $207.36 $12,796 - $20,736
-100 Reduced 1.14%
8,700 $1.8 Million
Q4 2021

Jan 24, 2022

BUY
$165.13 - $241.83 $49,539 - $72,549
300 Added 3.53%
8,800 $1.57 Million
Q3 2021

Oct 22, 2021

SELL
$163.99 - $235.57 $16,399 - $23,557
-100 Reduced 1.16%
8,500 $1.75 Million
Q2 2021

Jul 26, 2021

BUY
$131.45 - $201.49 $289,190 - $443,278
2,200 Added 34.38%
8,600 $1.63 Million
Q1 2021

Apr 23, 2021

BUY
$92.73 - $142.05 $102,003 - $156,255
1,100 Added 20.75%
6,400 $833,000
Q4 2020

Jan 25, 2021

BUY
$67.44 - $103.72 $175,344 - $269,672
2,600 Added 96.3%
5,300 $549,000
Q3 2020

Dec 14, 2020

BUY
$42.79 - $75.8 $115,533 - $204,660
2,700 New
2,700 $204,000
Q3 2019

Oct 21, 2019

SELL
$29.71 - $55.23 $53,478 - $99,414
-1,800 Closed
0 $0
Q2 2019

Jul 25, 2019

BUY
$29.73 - $66.02 $53,514 - $118,836
1,800 New
1,800 $102,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.